Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

2-PyrazinecarboxaMide, N-[(1S)-2-[[(1S)-1-hydroperoxy-3-Methylbutyl]aMino]-2-oxo-1-(phenylMethyl)ethyl]-

Base Information Edit
  • Chemical Name:2-PyrazinecarboxaMide, N-[(1S)-2-[[(1S)-1-hydroperoxy-3-Methylbutyl]aMino]-2-oxo-1-(phenylMethyl)ethyl]-
  • CAS No.:886979-81-3
  • Molecular Formula:C19H24N4O4
  • Molecular Weight:372.41826
  • Hs Code.:
  • Mol file:886979-81-3.mol
2-PyrazinecarboxaMide, N-[(1S)-2-[[(1S)-1-hydroperoxy-3-Methylbutyl]aMino]-2-oxo-1-(phenylMethyl)ethyl]-

Synonyms:2-PyrazinecarboxaMide, N-[(1S)-2-[[(1S)-1-hydroperoxy-3-Methylbutyl]aMino]-2-oxo-1-(phenylMethyl)ethyl]-;N-((S)-1-(((S)-1-hydroperoxy-3-Methylbutyl)aMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide;Bortezomib Impurity 13;Bortezomib Impurity 4

Suppliers and Price of 2-PyrazinecarboxaMide, N-[(1S)-2-[[(1S)-1-hydroperoxy-3-Methylbutyl]aMino]-2-oxo-1-(phenylMethyl)ethyl]-
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • TRC
  • (S,S)-HydroperoxyDes(boricAcid)Bortezomib
  • 5mg
  • $ 2035.00
  • TRC
  • (S,S)-HydroperoxyDes(boricAcid)Bortezomib
  • 2.5mg
  • $ 1275.00
Total 13 raw suppliers
Chemical Property of 2-PyrazinecarboxaMide, N-[(1S)-2-[[(1S)-1-hydroperoxy-3-Methylbutyl]aMino]-2-oxo-1-(phenylMethyl)ethyl]- Edit
Chemical Property:
  • Boiling Point:709.0±60.0 °C(Predicted) 
  • PKA:10.96±0.10(Predicted) 
  • PSA:113.44000 
  • Density:1.227±0.06 g/cm3(Predicted) 
  • LogP:2.57750 
  • Storage Temp.:-20°C Freezer 
  • Solubility.:Chloroform (Slightly), DMSO (Slightly) 
Purity/Quality:

NLT 98% *data from raw suppliers

(S,S)-HydroperoxyDes(boricAcid)Bortezomib *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:
Useful:
  • Uses (S,S)-Hydroperoxy Des(boric Acid) Bortezomib is an impurity of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer
Post RFQ for Price